Published by Josh White on 30th January 2024
(Sharecast News) - Pharmaceutical and medical technology service company Uniphar said in an update on Tuesday that its performance in 2023 met its own expectations in terms of gross profit and EBITDA, while also achieving normalised free cash flow conversion in line with medium-term guidance.
URL: http://www.digitallook.com/dl/news/story/34056751/...